Development of a precision medicine pipeline to identify personalized treatments for colorectal cancer.
Erdem AltunelRoham S RoghaniKai-Yuan ChenSo Young KimShannon McCallKathryn E WareXiling ShenJason A SomarelliShiao-Wen D HsuPublished in: BMC cancer (2020)
Our data suggests that the use of matched low-passage cell lines and PDXs is a promising strategy to identify new therapies and pathways to treat metastatic CRC.